Next Article in Journal
Digital Medical Catalog: Harnessing AI for Automated Classification and Analysis of Medical Data
Previous Article in Journal
Genetic and Epigenetic Algorithms Optimization of U-Net Architectures for Low-Dose Scintigraphy Image Reconstruction
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Launch Editorial of AI in Medicine

by
Pierre Boulanger
1,2
1
Department of Computing Science, University of Alberta, Edmonton, AB T6G 2E8, Canada
2
Department of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, AB T6G 2E8, Canada
AI Med. 2026, 1(1), 9; https://doi.org/10.3390/aimed1010009
Submission received: 23 March 2026 / Accepted: 23 March 2026 / Published: 26 March 2026
Distinguished colleagues in the global medical and AI communities,
As artificial intelligence reshapes the boundaries of human knowledge, medicine stands at the threshold of its most profound transformation since the advent of evidence-based practice, moving from intuition-guided clinical judgment to a model co-driven by data and intelligence and advancing from population-level statistical inference to precision, patient-specific optimization. This transformation is already tangible in every dimension of the clinical enterprise: Deep learning is achieving clinician-level performance in disease detection, diagnosis, prediction, and treatment from oncology to cardiology [1]. AI is redefining the sensitivity and throughput of medical image analysis, spanning radiological screening, digital pathology, and multimodal imaging [2]. Clinical decision support systems are synthesizing heterogeneous patient data from laboratory values, vital signs, and clinical notes to deliver high diagnostic and prognostic accuracy at the bedside [3]. Natural language processing unlocks actionable insight from unstructured electronic health records, transforming medical informatics and enabling medical data processing at unprecedented scales [4]. In genomics and precision medicine, multi-omics integration enables patient-specific therapeutic strategies tailored to individual biology [5], whereas AI-guided drug discovery and development pipelines, including clinical trial design and recruitment, are compressing timelines from years to months [6]. Intelligent devices and instruments are embedding diagnostic intelligence at the point of care; remote monitoring and telemedicine are expanding access to expertise across geographic and socioeconomic boundaries; AI-driven rehabilitation and assistive technologies are opening new pathways to recovery for patients with chronic disease and disability [7]. However, these advances bring formidable responsibilities: many systems remain opaque “black boxes” that limit clinician trust, dataset biases threaten equitable performance across diverse populations [8], and AI-driven diagnostics and patient care pose ethical challenges. To advance rigorous, reproducible, and responsible research across this full spectrum, AI in Medicine is launched today as an international open-access journal dedicated to artificial intelligence and computer science techniques applied to medicine, guided always by the foundational principle of our profession: first, do no harm.

Conflicts of Interest

The author declares no conflicts of interest.

References

  1. Ogut, E. Artificial Intelligence in Clinical Medicine: Challenges Across Diagnostic Imaging, Clinical Decision Support, Surgery, Pathology, and Drug Discovery. Clin. Pract. 2025, 15, 169. [Google Scholar] [CrossRef] [PubMed]
  2. Khalifa, M.; Albadawy, M. AI in Diagnostic Imaging: Revolutionising Accuracy and Efficiency. Comput. Methods Programs Biomed. Update 2024, 5, 100146. [Google Scholar] [CrossRef]
  3. Khalifa, M.; Albadawy, M. AI-Powered Clinical Decision Support Systems in Disease Diagnosis, Treatment Planning, and Prognosis: A Systematic Review. Med. J. Islam. Repub. Iran 2025, 39, 81. [Google Scholar] [CrossRef]
  4. Kresevic, S.; Giuffrè, M.; Ajcevic, M.; Accardo, A.; Crocè, L.S.; Shung, D.L. Optimization of Hepatological Clinical Guidelines Interpretation by Large Language Models: A Retrieval Augmented Generation-Based Framework. npj Digit. Med. 2024, 7, 102. [Google Scholar] [CrossRef] [PubMed]
  5. Hasanzad, M.; Nosrati, M.; Khatami, F.; Rahmani, P.; Sarhangi, N.; Nikfar, S.; Abdollahi, M. Drug Discovery in the Context of Precision Medicine and Artificial Intelligence. Expert Rev. Precis. Med. Drug Dev. 2024, 20, 42–53. [Google Scholar] [CrossRef]
  6. Serrano, D.R.; Luciano, F.C.; Anaya, B.J.; Ongoren, B.; Kara, A.; Molina, G.; Ramirez, B.I.; Sánchez-Guirales, S.A.; Simon, J.A.; Tomietto, G.; et al. Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine. Pharmaceutics 2024, 16, 1328. [Google Scholar] [CrossRef] [PubMed]
  7. Bhushan, A.; Misra, P. Unlocking the Potential: Multimodal AI in Biotechnology and Digital Medicine Economic Impact and Ethical Challenges. npj Digit. Med. 2025, 8, 619. [Google Scholar] [CrossRef] [PubMed]
  8. Ueda, D.; Kakinuma, T.; Fujita, S.; Kamagata, K.; Fushimi, Y.; Ito, R.; Matsui, Y.; Nozaki, T.; Nakaura, T.; Fujima, N.; et al. Fairness of Artificial Intelligence in Healthcare: Review and Recommendations. Jpn. J. Radiol. 2024, 42, 3–15. [Google Scholar] [CrossRef] [PubMed]

Short Biography of Author

Prof. Dr. Pierre Boulanger is Professor Emeritus at the University of Alberta, where he held dual appointments in the Department of Computing Science and the Department of Radiology and Diagnostic Imaging. Over a distinguished career spanning four decades, he served for 18 years as a Senior Research Officer at the National Research Council of Canada (1983–2001) before joining the University of Alberta as a Full Professor (2001–2025), where he founded and directed the Advanced Human–Computer Interface Laboratory. From 2013 to 2023, he held the CISCO Chair in Healthcare Solutions, a $2 million endowed research chair dedicated to the application of network technologies and artificial intelligence in clinical care. He continues to serve as Scientific Director of the SERVIER Virtual Cardiac Centre. Dr. Boulanger’s research consistently operated at the intersection of computation and medicine, with contributions spanning 3D sensing, patient-specific surgical simulation, medical image analysis, and, most recently, robotic multi-view ultrasound imaging. This body of work encompasses 434 peer-reviewed publications, 4585 citations, and an h-index of 34. His current research focuses on three converging frontiers: multi-view ultrasound image processing, geometry-aware deep neural networks, and AI-driven clinical predictive systems. The latter is embodied in his MedROAD platform where AI-based clinical decision support is used to deliver state-of-the-art medicine to patients in remote regions.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Boulanger, P. Launch Editorial of AI in Medicine. AI Med. 2026, 1, 9. https://doi.org/10.3390/aimed1010009

AMA Style

Boulanger P. Launch Editorial of AI in Medicine. AI in Medicine. 2026; 1(1):9. https://doi.org/10.3390/aimed1010009

Chicago/Turabian Style

Boulanger, Pierre. 2026. "Launch Editorial of AI in Medicine" AI in Medicine 1, no. 1: 9. https://doi.org/10.3390/aimed1010009

APA Style

Boulanger, P. (2026). Launch Editorial of AI in Medicine. AI in Medicine, 1(1), 9. https://doi.org/10.3390/aimed1010009

Article Metrics

Back to TopTop